Cryo-Cell International, Inc. (CCEL)

Revenue by Segment

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2018	Nov 30, 2017	Nov 30, 2016
Umbilical Cord Blood and Cord Tissue Stem Cell Service	31.38M	31.55M	30.80M	29.77M	28.40M
Public Cord Blood Banking	129.51K	366.67K	481.15K	461.63K	376.10K
Prepacyte CB	54.10K	67.88K	66.46K	104.00K	111.40K
Total	31.57M	31.99M	31.34M	30.34M	28.88M

Data Source: S&P Global Market Intelligence Last updated: Oct 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 15, 2026

Data Sources Report a data error